The continuum of thyroid disorders related to immune checkpoint inhibitors: Still many pending queries MV Deligiorgi, S Sagredou, L Vakkas, DT Trafalis Cancers 13 (21), 5277, 2021 | 15 | 2021 |
8-Hydroxy-2’-Deoxyguanosine and 8-nitroguanine production and detection in blood serum of breast cancer patients in response to postoperative complementary external ionizing … KE Verigos, S Sagredou, K Orfanakos, P Dalezis, DT Trafalis Dose-Response 18 (4), 1559325820982172, 2020 | 6 | 2020 |
Discovery of steroidal lactam conjugates of POPAM-NH2 with potent anticancer activity D Trafalis, P Dalezis, E Geromichalou, S Sagredou, E Sflakidou, M Voura, ... Future Medicinal Chemistry 12 (1), 19-35, 2020 | 6 | 2020 |
3,6-Disubstituted 1,2,4-Triazolo[3,4-b]Thiadiazoles with Anticancer Activity Targeting Topoisomerase II Alpha S Sagredou, P Dalezis, N Nikoleousakos, M Nikolaou, M Voura, ... OncoTargets and therapy, 7369-7386, 2020 | 5 | 2020 |
Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation DT Trafalis, S Sagredou, P Dalezis, M Voura, S Fountoulaki, ... Pharmaceutics 13 (4), 493, 2021 | 4 | 2021 |
Azasteroid Alkylators as dual inhibitors of AKT and ERK signaling for the treatment of ovarian carcinoma P Dalezis, E Geromichalou, A Polonifi, S Sagredou, N Nikoleousakos, ... Cancers 12 (5), 1263, 2020 | 4 | 2020 |
Cytocidal Antitumor Effects against Human Ovarian Cancer Cells Induced by B-Lactam Steroid Alkylators with Targeted Activity against Poly (ADP-Ribose) Polymerase (PARP) Enzymes … N Nikoleousakos, P Dalezis, A Polonifi, EG Geromichalou, S Sagredou, ... Biomedicines 9 (8), 1028, 2021 | 2 | 2021 |
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden S Sagredou, P Dalezis, E Papadopoulou, M Voura, MV Deligiorgi, ... Pharmaceutics 13 (6), 885, 2021 | 1 | 2021 |